Tools hub
Financial Calculators
Private, in-browser — no account required.
NYSE · Healthcare
$251.92
▼ -$4.55(-1.77%)9:30 AM ET - vs previous closeiQuote as of Sep 8, 2026, 9:30 AM EDT
Realtime NYSE quote as of Sep 8, 2026, 9:30 AM EDT.
Market data source
Evidence
59/100
Thin evidence
Session
-1.77%
vs 256.46 prior close
52-week range
80%
of the 190.75–267.47 range
Consensus target
+9.8%
to 276.59 consensus
TECHi stance
Balanced watch
Model confidence 49/100 · 59/76 inputs
Chart
Latest 1D session
1Y · daily bars · USD · Live $251.92 · 254 pts
Live checkTrade access
Affiliate disclosure: TECHi may earn a commission on links to broker partners. Read more.
Prices update fastest. Fundamentals, analyst data, and news update on their own schedules, so check these timestamps before comparing signals.
Price time means the latest available trade or regular-market close. Other times show when that section was checked or published.
Investor playbook
The page is most useful as a monitor until one side gets cleaner confirmation.
Use it for
Entry timing, risk check, and catalyst scan
What has to keep working for US investors to stay interested.
Trend support
+11.6%Current price is above the 200-day average.
Cash yield
4.1%$18.21B free-cash-flow base.
Where the dashboard says the thesis can break or get crowded.
Premium multiple
70.94Trailing P/E is high enough that earnings misses can matter fast.
Estimate cuts
-19 net20 EPS cuts vs 1 increases in 30 days.
The playbook is derived from quote, analyst, financial, news, and trend snapshots. It is a research workflow aid, not a buy or sell recommendation.
Upcoming events
ABBV reports on Oct 29, 2026.
Countdown
51 days out
As of Sep 8, 2026, 9:30 AM EDT, AbbVie Inc. (ABBV) traded at $251.92, a -1.77% move versus the prior close, ranging between $248.90 and $254.62 intraday, and on volume of 77.47K shares. The stock has traded between $190.75 and $267.47 over the past 52 weeks, carries a market capitalization of $443.74B, trades at 70.94x trailing earnings, and yields 2.7% in dividends. Sell-side analysts rate ABBV Buy across 39 ratings and carry an average price target of $276.59 (+9.79% implied versus the last quote). ABBV's record close stands at $267.47, set on Jul 29, 2026.
Buy analyst tone.
Balanced watch. Track record validation (83/100) is the strongest signal; news sentiment (0/100) is the main constraint. Model confidence is 49/100 — some inputs are unavailable, so treat this as a directional research screen rather than a forecast. Long-term secular context is tracked separately: 5 Years +176% total; yesterday -1.4%. Comparable past signals have verified against subsequent prices 20.6% of the time.
Expected-return math is scaled by beta and realized volatility before confidence is applied.
Short-horizon expected moves are volume-weighted so thin moves get less credit than confirmed tape.
Sector momentum is included beside the broader market regime.
| Enterprise value | $445.51B |
| Operating margin | 51.51% |
| Return on assets | 4.67% |
| EPS (TTM) | $3.54 |
| Beta (5Y) | 0.28 |
Benchmark context
Compare against its sector ETF and the broad market.
Help · FAQ
2 answers covering latest price, and sector context.
TECHi displays provider-supplied values only when the corresponding field is present.
TECHi.com